{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:55:33Z","timestamp":1779173733097,"version":"3.51.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Efforts to develop a range of HIV prevention products that can serve as behaviorally congruent viable alternatives to consistent condom use and oral pre-exposure prophylaxis (PrEP) remain crucial. MTN-035 was a randomized crossover trial seeking to evaluate the safety, acceptability, and adherence to three placebo modalities (insert, suppository, enema) prior to receptive anal intercourse (RAI). If participants had no RAI in a week, they were asked to use their assigned product without sex. We hypothesized that the modalities would be acceptable and safe for use prior to RAI, and that participants would report high adherence given their behavioral congruence with cleansing practices (e.g., douches and\/or enemas) and their existing use to deliver medications (e.g., suppositories; fast-dissolving inserts) via the rectum. Participants (N = 217) were sexual and gender minorities enrolled in five different countries (Malawi, Peru, South Africa, Thailand, and the United States of America). Mean age was 24.9 years (range 18\u201335 years). 204 adverse events were reported by 98 participants (45.2%); 37 (18.1%) were deemed related to the study products. The proportion of participants reporting \u201chigh acceptability\u201d was 72% (95%CI: 65% - 78%) for inserts, 66% (95%CI: 59% - 73%) for suppositories, and 73% (95%CI: 66% - 79%) for enemas. The proportion of participants reporting fully adherent per protocol (i.e., at least one use per week) was 75% (95%CI: 69% - 81%) for inserts, 74% (95%CI: 68% - 80%) for suppositories, and 83% (95%CI: 77% - 88%) for enemas. Participants fully adherent per RAI-act was similar among the three products: insert (n = 99; 58.9%), suppository (n = 101; 58.0%) and enema (n = 107; 58.8%). The efficacy and effectiveness of emerging HIV prevention drug depends on safe and acceptable delivery modalities that are easy to use consistently. Our findings demonstrate the safety and acceptability of, and adherence to, enemas, inserts, and suppositories as potential modalities through which to deliver a rectal microbicide.<\/jats:p>","DOI":"10.1371\/journal.pone.0284339","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T17:35:22Z","timestamp":1681320922000},"page":"e0284339","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035)"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-2306","authenticated-orcid":true,"given":"Jose A.","family":"Bauermeister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Dominguez Islas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Tingler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Zemanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Giguere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Balan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Macagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-3950","authenticated-orcid":true,"given":"Edward","family":"Livant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Hoesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Kayange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwat","family":"Chariyalertsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2610-0136","authenticated-orcid":true,"given":"Pedro","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanna","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on Behalf of the MTN-035 Protocol Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"pone.0284339.ref001","author":"UNAIDS","year":"2020","journal-title":"Global HIV & AIDS Statistics\u20142020 Fact Sheet unaids.org"},{"issue":"9","key":"pone.0284339.ref002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"RM Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pone.0284339.ref003","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1007\/s10461-020-02855-9","article-title":"Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.","volume":"24","author":"A Hillis","year":"2020","journal-title":"AIDS Behav"},{"issue":"3","key":"pone.0284339.ref004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/08964289.2020.1731675","article-title":"Are Sexual Minority Stressors Associated with Young Men who Have Sex with Men\u2019s (YMSM) Level of Engagement in PrEP?","volume":"47","author":"S Meanley","year":"2021","journal-title":"Behav Med."},{"key":"pone.0284339.ref005","article-title":"Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation.","author":"SK Calabrese","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9","key":"pone.0284339.ref006","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1377\/hlthaff.2020.00242","article-title":"State-Level Discrimination Policies And HIV Pre-Exposure Prophylaxis Adoption Efforts In The US.","volume":"39","author":"S Bonett","year":"2020","journal-title":"Health Aff (Millwood)."},{"key":"pone.0284339.ref007","article-title":"Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color","author":"S Wood","year":"2019","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0284339.ref008","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1071\/SH18191","article-title":"Providing competent, comprehensive and inclusive sexual health services for men who have sex with men in low- and middle-income countries: a scoping review.","volume":"16","author":"CH Bien-Gund","year":"2019","journal-title":"Sex Health"},{"issue":"3","key":"pone.0284339.ref009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11904-020-00497-z","article-title":"PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men.","volume":"17","author":"JA Bauermeister","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"pone.0284339.ref010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11904-019-00450-9","article-title":"Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.","volume":"16","author":"MR Beymer","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"pone.0284339.ref011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/17425247.2013.860132","article-title":"The development of rectal microbicides for HIV prevention","volume":"11","author":"I. McGowan","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"pone.0284339.ref012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/09540121.2018.1557590","article-title":"Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment","volume":"31","author":"A Dubov","year":"2019","journal-title":"AIDS Care"},{"issue":"12","key":"pone.0284339.ref013","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1007\/s10461-017-1969-1","article-title":"Preference of Oral Tenofovir Disoproxil Fumarate\/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men","volume":"21","author":"A Carballo-Dieguez","year":"2017","journal-title":"AIDS Behav"},{"key":"pone.0284339.ref014","article-title":"Acceptability of a Dapivirine\/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).","author":"JA Bauermeister","year":"2021","journal-title":"AIDS Behav"},{"issue":"5","key":"pone.0284339.ref015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1521\/aeap.2021.33.5.361","article-title":"Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).","volume":"33","author":"JA Bauermeister","year":"2021","journal-title":"AIDS Educ Prev"},{"issue":"4","key":"pone.0284339.ref016","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10508-016-0735-1","article-title":"Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.","volume":"46","author":"T Frasca","year":"2017","journal-title":"Arch Sex Behav"},{"issue":"5","key":"pone.0284339.ref017","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/aid.2016.0167","article-title":"A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability","volume":"33","author":"ED Weld","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pone.0284339.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/aeap.2016.28.1.1","article-title":"To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction among Young Men Who Have Sex with Men","volume":"28","author":"J Bauermeister","year":"2016","journal-title":"Aids Education and Prevention"},{"key":"pone.0284339.ref019","first-page":"40","article-title":"Comparing applicator vs. \"as lubricant\" delivery of rectal dapivirine gel (MTN-033)","volume":"24","author":"K Ho","year":"2021","journal-title":"Journal of the International AIDS Society"},{"issue":"4","key":"pone.0284339.ref020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1521\/aeap.2022.34.4.257","article-title":"Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).","volume":"34","author":"JA Bauermeister","year":"2022","journal-title":"AIDS Educ Prev"},{"key":"pone.0284339.ref021","article-title":"Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche.","author":"A Carballo-Dieguez","year":"2018","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0284339.ref022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/OLQ.0b013e3181bf9b2d","article-title":"Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men.","volume":"37","author":"A Carballo-Dieguez","year":"2010","journal-title":"Sex Transm Dis"},{"key":"pone.0284339.ref023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-med-090518-093731","article-title":"Topical Microbicides in HIV Prevention: State of the Promise.","volume":"71","author":"JM Baeten","year":"2020","journal-title":"Annu Rev Med."},{"issue":"5","key":"pone.0284339.ref024","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s10461-019-02662-x","article-title":"Rectal Douching and Microbicide Acceptability among Young Men who Have Sex with Men","volume":"24","author":"RC Tingler","year":"2020","journal-title":"AIDS Behav"},{"issue":"3","key":"pone.0284339.ref025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10461-012-0358-z","article-title":"Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial","volume":"17","author":"HA Pines","year":"2013","journal-title":"AIDS Behav"},{"issue":"6","key":"pone.0284339.ref026","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/sti.2008.030478","article-title":"Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men.","volume":"84","author":"A Carballo-Dieguez","year":"2008","journal-title":"Sex Transm Infect."},{"key":"pone.0284339.ref027","doi-asserted-by":"crossref","first-page":"100930","DOI":"10.1016\/j.conctc.2022.100930","article-title":"Overcoming COVID-19 disruptions: Innovations in product provision in a multi-national clinical trial among cisgender men, transgender men and transgender women in five countries.","volume":"28","author":"C Jacobson","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"key":"pone.0284339.ref028","volume-title":"Division of AIDS (DAIDS) Tabel for Grading the Severity of Adult and Pediatric Adverse Events.","author":"Division of AIDS NIoAaID","year":"2017"},{"key":"pone.0284339.ref029","volume-title":"Table for grading the severity of adult and pediatric adverse events\u2014Addendum 1\u2014Female Genital Grading Table for Use in Microbicide Studies.","author":"Division of AIDS NIoAaID","year":"2007"},{"key":"pone.0284339.ref030","volume-title":"Table for grading the severity of adulut and pediatric adverse events\u2014Addendum 2\u2014Male genital grading table for use in microbicide studies","author":"Division of AIDS NIoAaID","year":"2007"},{"key":"pone.0284339.ref031","volume-title":"Table for grading the severity of adult and pediatric adverse events-Addendum 3\u2014Rectal Grading Table for Use in Microbicide Studies, Clarification","author":"Division of AIDS NIoAaID","year":"2012"},{"issue":"11","key":"pone.0284339.ref032","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s10461-015-1258-9","article-title":"Acceptability and Preferences for Hypothetical Rectal Microbicides among a Community Sample of Young Men Who Have Sex with Men and Transgender Women in Thailand: A Discrete Choice Experiment","volume":"20","author":"PA Newman","year":"2016","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0284339.ref033","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s10461-017-1959-3","article-title":"Rectal Douching Associated with Receptive Anal Intercourse: A Literature Review.","volume":"22","author":"A Carballo-Dieguez","year":"2018","journal-title":"AIDS Behav"},{"issue":"6","key":"pone.0284339.ref034","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10461-011-0045-5","article-title":"Using conjoint analysis to measure the acceptability of rectal microbicides among men who have sex with men in four South American cities","volume":"16","author":"JJ Kinsler","year":"2012","journal-title":"AIDS Behav"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T17:35:42Z","timestamp":1681320942000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284339"}},"subtitle":[],"editor":[{"given":"Renee","family":"Ridzon","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284339","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]}}}